Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nolato year-end report: Strong financial position and proposed increase in dividend

Fourth quarter of 2018: · Sales totalled SEK 1,781 million (1,926) · Operating profit (EBITA) was SEK 214 million (230) · EBITA margin of 12.0% (11.9) · Profit after tax was SEK 158 million (180) · Basic earnings per share were SEK 6.01 (6.84) · Cash flow after investment was SEK 122 million (157) Medical Solutions sales for the fourth quarter increased to SEK 580 million (511). Adjusted for currency, sales increased by a strong 8%. Operating profit (EBITA) rose to SEK 77 million (68). The EBITA margin was 13.3% (13.3). “Sales increased in both Medical Devices and

#19-334 Listing of Mini futures issued by Vontobel Financial Products GmbH

As from February 13, 2019, 2 Mini futures issued by Vontobel Financial Products GmbH will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Vontobel Financial Products GmbH Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from February 13, 2019 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AG Underlying: OMXS30 index Silver (troy ounce) Current values of strike and barrier can be found at: [ NGM Market

Key information relating to the cash dividend to be paid by Bonheur ASA

In a meeting 11 February 2019, the Board of Directors resolved to propose for the annual general meeting an ordinary dividend for 2018 of NOK 4.00 per share.  Dividend amount: 4.00 per share  Declared currency: NOK  Last day including right: 28 May 2019  Ex-date: 29 May 2019  Record date: 31 May 2019  Payment date: 10 June 2019  Date of approval: 28 May 2019  This information is published in accordance with the requirements of the rules on the continuing obligations of stock exchange listed companies.

Improved result for the third year in row

Fourth quarter · Turnover MSEK 414.3 (367.2), up 13 percent compared to previous year · Operating profit MSEK 24.0 (24.8) · Operating margin 5.8 percent (6.8) · Net income MSEK 17.7 (18.5) · Cash flow from operating activities MSEK 54.0 (24.6) · Earnings per share SEK 2.13 kr (2.55) Year 2018 · Turnover MSEK 1 618.3 (1 382.8), up 17 percent compared to previous year · Operating profit MSEK 113.7 (103.9) · Operating margin 7.0 percent (7.5) · Net income MSEK 83.5 (77.3) · Cash flow from operating activities MSEK 129.8 (85.5) · Earnings per share SEK

Bellman Group carries out an internal restructuring in order to simplify its legal group structure

Bellman Group AB (publ) (the “Company” or “Bellman Group”) has initiated certain intragroup transactions in order to simplify the structure of the group. After the restructuring, the group will still consist of four brands, Uppländska Berg, Bellmans, VSM and Samgräv.After the internal restructuring, the Company will have four direct subsidiaries, being Bellmans Åkeri & Entreprenad AB, Uppländska Bergborrnings Aktiebolaget, VSM Entreprenad AB and Samgräv Holding AB. Through the internal restructuring, the group will become more cost effective since part of the administrative work carried

Immunovia AB announces appointment of Senior Director of Investor Relations

LUND, SWEDEN - (Nasdaq Stockholm: IMMNOV), to strengthen IR and shareholder communication Immunovia today announced that Julie Silber has joined as Director of Investor Relations. Bringing over 18+ years of investor relations, strategic communications, counsel and executive financial leadership experience, Julie has served as a trusted advisor to small and medium size public companies as both an Investor Relations Officer and CFO. She has been instrumental in executing all facets of the IR function and leveraging her deep institutional investor knowledge and business consulting expertise. She

Alligator Bioscience to Host Conference Call to Provide Year-end Report 2018 Business Update

Alligator Bioscience (Nasdaq Stockholm: ATORX) - On 14 February 2019, at 08:00 a.m. CET, Alligator Bioscience will publish its report for the year ended 31 December 2018. All interested parties are invited to participate in a telephone conference, which will include a presentation of the Year-end Report, on the same day at 09:00 a.m. CET. The event will be hosted by CEO Per Norlén and the presentation will be held in English.  When: 09:00 a.m. CET Thursday 14 February 2019 Listen to the presentation: https://financialhearings.com/event/11461 To participate in the telephone

Sedana Medical receives go-ahead for pediatric study  - Milestone on the road to market exclusivity

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces the company has been approved for its planned pediatric study from the Pediatric Committee of EMA, European Medicines Agency, (PDCO).A complete Marketing Authorization Application (MAA) for drugs in EU must include a PDCO agreed and approved study plan for children, a so-called PIP (Pediatric Investigation Plan). "It is incredibly satisfying that PDCO has now approved our planned pediatric study, our PIP. An approved study plan on children is one of the prerequisites for a European market approval for our therapy, so this is

Invitation to Presentation of SimCorp’s Annual Report 2018

PRESS RELEASE SimCorp will publish its Annual Report 2018 to NASDAQ Copenhagen on Wednesday, February 20, 2019 at around 8:00 am (CET). SimCorp’s Executive Management Board will present the report at a conference call the same day at 11:00 am (CET). Please use any of the following phone numbers to dial in to the conference call: From Denmark: +45 3272 8042From USA: +1 631 510 7495From other countries: +44 (0) 2071 928000Pin code to access the call: 2748549 At the end of the presentation there will be a Q&A session.It will also

Welcome to AddLife’s Capital Markets Day 18 February 2019

Analysts, professional investors and media are welcome to AddLife’s Capital Markets Day on Monday 18 February 2019 10:00am at Scandic Anglais, Humlegårdsgatan 23, Stockholm. Registration from 9:30am. The meeting is expected to end around noon, when lighter lunch will be offered.AddLife’s CEO Kristina Willgård will speak, together with the management team. The purpose of the Capital Markets Day is uppermost to portray the company’s development and further strategy as well as to present the acquisitions of the previous year.Registration is made to kerstin.kocas@add.life at the latest

HiQ becomes digital partner of Swedish Automobile Sports Federation

HiQ is initiating a collaboration with Svenska Bilsportförbundet, the Swedish Automobile Sports Federation. HiQ will support the federation in its efforts to develop digital solutions, systems and services that improve and simplify life for motorsport enthusiasts throughout Sweden.“Being involved with motorsport is a perfect fit for us. It’s a form of competition that can use innovative solutions to make a big difference. We have had several collaborative projects over the years, and the drivers, teams and the entire sport have also helped us evolve as a company,” says Erik Ridman, Head of

Kamux is increasing its selection of cars in Lahti by relocating showrooms

Kamux Corporation Press Release, 12 February 2019 at 14:00    Kamux is increasing its selection of cars in Lahti by relocating showrooms Kamux, a company specialising in used car sales, is continuing its strong growth and increasing its selection of cars in Lahti by relocating showrooms.   Both passenger cars and utility vehicles into larger showrooms in July “From the beginning of July, we will relocate Kamux’s Lahti passenger car showroom to new premises at Laatukaari 1. The new location will enable us to have a larger selection of cars in our showroom. At the same time,

Invitation to presentation of Scandic’s year-end report 2018

Scandic Hotels Group will present its year-end report for 2018 in a webcast at 9.00 CET on February 19, 2019. The report will be published at 7.30 CET on the same day.Scandic’s CFO Jan Johansson will present the report together with President & CEO Jens Mathiesen in a webcast and telephone conference. The presentation will be held in English. Time: Tuesday, February 19, 2019 at 09:00 CETLocation: Webcast and telephone conferenceTelephone numbers: SE: +46850558350 UK: +443333009032  Please call in 5 minutes before the start. You can view the webcast at scandichotelsgroup.com (

BAKKAFROST: Invitation to Presentation/Webcast of Q4 2018 results 19 February 2019 at 8:00 am (CET)

Q4 2018 PRESENTATION A presentation of Bakkafrost’s interim report Q4 2018 will be held at 8:00 am (CET) on 19 February 2019 at Hotel Continental, Stortingsgaten 24/26, Oslo, Norway. WEBCAST The presentation will be transmitted live on Bakkafrost's website www.bakkafrost.com. Bakkafrost´s interim report Q4 2018 and presentation will be released prior to market opening on 19 February 2019 at 6:00 am (CET). Contacts: Regin Jacobsen, CEO of P/F Bakkafrost: +298 235001 (mobile) Gunnar Nielsen, CFO of P/F Bakkafrost: +298 235060 (mobile) This information is subject of the

Glaston’s Financial Statement Bulletin 1 January – 31 December 2018: Good fourth quarter – orders received grew and comparable operating profit improved

GLASTON CORPORATION   FINANCIAL STATEMENT BULLETIN       12 FEBRUARY 2019 AT 13.00This release is a summary of Glaston Corporation's financial statements bulletin for 2018. The complete report is attached to this release as a pdf-file. The stock exchange release is also available on the company's website at the address www.glaston.net.FOURTH QUARTER 2018 IN BRIEF ·  Orders received grew by 18% and totaled EUR 33.9 (28.8) million.   ·  Net sales totaled EUR 27.8 (29.7) million.   ·  Comparable EBITDA was EUR 3.2 (2.2) million, 11.5 (7.3)% of net sales.   ·  The operating

Saab to Deliver Carl-Gustaf M4 to the U.S. Army

Saab and the U.S. Army have signed a multi-year framework agreement for delivery of the Carl-Gustaf® M4 weapon system (designated M3E1 in the US). The first delivery order amounts to USD 19 million (Approximately 170 MSEK) with deliveries expected in 2019.The recently signed framework contract has a duration of 3 years and gives the U.S. Army the opportunity to place orders for Carl-Gustaf M4 systems for a total value of approximately 380 MSEK. The Carl-Gustaf 84-mm recoilless rifle is a combat-proven system capable of operating in demanding environments that provides soldiers with clear

NRC Group ASA - Appointed to a contract in Finland - EUR 10.9 million

Tampere Tramway Ltd has appointed Tampere Tramway Alliance, in which NRC Finland Oy, a company wholly owned by NRC Group ASA, is a participant, to a contract for tramway maintenance work in Tampere city center in Finland. The contract will involve the maintenance of the new tramline in the city of Tampere, where the commercial traffic is due to begin in 2021. The contract is divided into a development phase which commences in February 2019 and ends in May 2022 with an estimated contract value of EUR 4.6 million. The maintenance phase commences in May 2022 and ends in February 2029

Peab builds waste rock transport out facility in Kiruna

Peab has been commissioned to build a new waste rock transport out facility for LKAB’s sorting plant in Kiruna. The customer is LKAB and the contract is worth SEK 125 million.The new facility will have a capacity level of 35 tons annually as well as improve the work environment in the plant. Construction will mostly take place while the plant is in operation and the facility will be connected during a planned stop in operations. The project is a turnkey contract in partnership and construction will begin in February 2019. It is expected to be completed in September 2020. The project

Clinical results for Episealer® to be presented at German clinical congress

Episurf Medical (NASDAQ: EPIS B) today announces that the scientific abstract “Erfolgreiche klinische Ergebnisse mit einer patienten-spezifischen Endoprothese zur Behandlung von fokalen, vollschichtigen Knorpelschäden des Kniegelenks” (Eng: Successful clinical results of an individualised endoprosthesis for treatment of focal full-thickness cartilage lesions in the knee) by Dr. med. Johannes Holz et al. will be presented at the German annual congress of EKB2019 (Endoprothetikkongress Berlin). The congress will take place in Berlin, Germany on February 14-16, 2019. The abstract focuses on

Calliditas Therapeutics granted orphan drug designation by the FDA for Primary biliary cholangitis

Calliditas Therapeutics AB (publ) (”Calliditas”) today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to the company for the treatment of Primary biliary cholangitis (PBC). More information about the ODD has been posted on www.fda.gov.PBC, previously known as primary biliary cirrhosis, is an autoimmune disease of the liver, where common symptoms are tiredness, itching and, in more advanced cases, jaundice. PBC is a rare disease, affecting approximately 4.3 people in 10,000 in US. It is much more common in women, with a ratio of at least 9:

Loopia Group acquires WebSupport, the #1 web hosting company in Slovakia

WebSupport, headquartered in Bratislava, is a major Central European provider of web hosting and web services to over 100,000 customers in Slovakia and Hungary. Part of the growing local tech community, WebSupport has an impressive history of high customer satisfaction and double-digit growth. Besides hosting, it offers domain registration and cloud infrastructure-services to consumers and small & medium sized companies. – We are excited to welcome the WebSupport team into the Loopia Group as we continue our growth journey. Over the past three years the team has shown how extraordinary

Increased demand in the US for Miris Human Milk Analyzer

As milk analyzer company Miris received clearance by US Food and Drug Administration (FDA) to market its Miris Human Milk Analyzer™ (HMA) in December, doctors in the US for the first time have access to a test to help analyze the nutrients in breast milk. Miris HMA™ has been available since 2006 and the instrument is registered as a Medical Device in Europe, and Japan and is now also available in the US.The interest for optimizing nutrition for preterm babies is growing in USA and the FDA approval has already proven to give effect as several Neonatal Intensive Care Units in the US have

Invitation to Skanska’s Capital Market Day 2019

Reminder: Invitation to Skanska’s Capital Market Day with a focus on Skanska’s performance and strategy.Date: March 21Registration 09:00 am, 09:30 am – 13:00 pm CET, followed by lunch.Venue: Kapitel 8 Klara Strand, Klarabergsviadukten 90, Stockholm. The Capital Market Day will provide insight into the strategy to improve profitability in Construction and how to continue creating value in Project Development, and how it is all connected to our Purpose of Building for a better society. Skanska’s senior management will be present and you will have the opportunity to ask your

Hahn Air Lines will resume successful summer route Dusseldorf-Palma de Mallorca in 2019

Press releaseDreieich, 12 February 2019. The German scheduled and executive charter airline Hahn Air Lines publishes its timetable for the 2019 summer schedule valid from 1st April 2019 to 25th October 2019. The only airline to operate scheduled flights with business jets, is pleased to announce that it will resume its seasonal service between Dusseldorf (DUS), Germany, and Palma de Mallorca (PMI), Spain, on Fridays and Sundays as per the schedule below: +------+-----+-------+---------+---------------+|Friday|HR220|DUS-PMI|1800-2005|Cessna Citation|+------+-----+-------+---------+----

There are no items matching the current filter
There are no more items matching the current filter
Back to top